Use of anti-connexin 43 polynucleotides for the treatment of abnormal or excessive scars

Details for Australian Patent Application No. 2008343758 (hide)

Owner CoDa Therapeutics, Inc.

Inventors Green, Colin R.; Duft, Bradford J.; Becker, David L.

Agent Spruson & Ferguson

Pub. Number AU-A-2008343758

PCT Pub. Number WO2009/085277

Priority 61/008,877 21.12.07 US

Filing date 22 December 2008

Wipo publication date 9 July 2009

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C12Q 1/00 (2006.01) Measuring or testing processes involving enzymes or micro-organisms

Event Publications

12 August 2010 PCT application entered the National Phase

  PCT publication WO2009/085277 Priority application(s): WO2009/085277

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008343762-Implantable device

2008343756-Use of anti-connexin polypeptide agent in combination with anti-connexin polynucleotide agent for the treatment of fibrotic conditions